Assessing combinations of cytotoxic agents using leukemia cell lines

Current Drug Targets

Volumn 8, Issue 6, 2007, Pages 765-771

  Reynolds, C Patrick ^a   Kang, Min H ^a   Keshelava, Nino ^a   Maurer, Barry J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

2 4 5 6 tetrabromofluorescein eosin Y; Combination index; Cytostatic assay; Cytotoxicity assay; Digital image microscopy; DIMSCAN; Fluorescein diacetate; Fluorescence

Indexed keywords

2 (2 DIMETHYLAMINOETHYL) 9 METHOXY 5 NITROPYRAZOLO[3,4,5 KL]ACRIDINE; ASPARAGINASE; DEXAMETHASONE; ETOPOSIDE; FENRETINIDE; FLUORESCEIN DIACETATE; FLUORESCENT DYE; ISOTRETINOIN; MELPHALAN; N [2 [(4 HYDROXYPHENYL)AMINO] 3 PYRIDINYL] 4 METHOXYBENZENESULFONAMIDE; SAFINGOL; VINCRISTINE; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CYTOTOXICITY TEST; DATA ANALYSIS SOFTWARE; DRUG MEGADOSE; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; LEUKEMIA CELL LINE; LOW DRUG DOSE; NEUROBLASTOMA; REVIEW; ARTICLE; CELL CULTURE; DOSE RESPONSE; DRUG SCREENING; FLUORESCENCE MICROSCOPY; LEUKEMIA; METHODOLOGY; MICROCOMPUTER; THEORETICAL MODEL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; HUMANS; LEUKEMIA; MICROCOMPUTERS; MICROSCOPY, FLUORESCENCE; MODELS, THEORETICAL; TUMOR CELLS, CULTURED;

EID: 34447530277     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945007780830845     Document Type: Review

References (42)

1. Pieters, R., Huismans, D. R., Leyva, A., and Veerman, A.J. (1989) Br. J. Cancer, 59, 217-220.
2. Rubinstein, L.V., Shoemaker, R.H., Paull, K.D., Simon, R.M., Tosini, S., Skehan, P., Scudiero, D.A., Monks, A., and Boyd, M.R. (1990) J. Natl. Cancer Inst., 82, 1113-1118.
3. Sobottka, S.B. and Berger, M.R. (1992) Cancer Chemother. Pharmacol., 30, 385-393.
4. Vistica, D.T., Skehan, P., Scudiero, D., Monks, A., Pittman, A., and Boyd, M.R. (1991) Cancer Res., 51, 2515-2520.
5. Gerson, S.L., Phillips, W., Kastan, M., Dumenco, L.L., and Donovan, C. (1996) BCNU. Blood, 88, 1649-1655.
6. Lee, C.K., Harman, G.S., Hohl, R.J., and Gingrich, R.D. (1996) Bone Marrow Transplant., 18, 573-577.
7. Dhar, S., Nygren, P., Csoka, K., Botling, J., Nilsson, K., and Larsson, R. (1996) Br. J. Cancer, 74, 888-896.
8. Ford, C.H., Richardson, V.J., and Tsaltas, G. (1989) Cancer Chemother. Pharmacol., 24, 295-301.
9. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S., and Boyd, M.R. (1990) J. Natl. Cancer Inst., 82, 1107-1112.
10. Leeder, J.S., Dosch, H.M., Harper, P.A., Lam, P., and Spielberg, S.P. (1989) Anal.Biochem., 177, 364-372.
11. Ross, D.D., Joneckis, C.C., Ordonez, J.V., Sisk, A.M., Wu, R.K., Hamburger AW Nora, R.E., and Nora, R.E. (1989) Cancer Res., 49, 3776-3782.
12. Wierda, W.G., Mehr, D.S., and Kim, Y.B. (1989) J. Immunol. Methods, 122, 15-24.
13. Nishio, K., Ishida, T., Arioka, H., Kurokawa, H., Fukuoka, K., Nomoto, T., Fukumoto, H., Yokote, H., and Saijo, N. (1996) Anticancer Res., 16, 3387-3395.
14. Bramson, J., OConnor, T., and Panasci, L. (1995) Biochem. Pharmacol., 50, 39-44.
15. Proffitt, R.T., Tran, J.V., and Reynolds, C.P. (1996) Cytometry, 24, 204-213.
16. Wang, X.M., Terasaki, P.I., Rankin, G.W., Jr., Chia, D., Zheng, H.P., and Hardy, S. (1993) Hum.Immunol., 37, 264-270.
17. Jensen, P.B., Holm, B., Sorensen, M., Christensen, I.J., and Sehested, M. (1997) Br. J. Cancer, 75, 869-877.
18. Reynolds, C.P. and Frgala, T. USPTO Patent Number 6, 459, 805, 10-1-2002.
19. Keshelava, N., Seeger, R.C., Groshen, S., and Reynolds, C.P. (1998) Cancer Res., 58, 5396-5405.
20. O'Donnell, P.H., Guo, W.X., Reynolds, C.P., and Maurer, B.J. (2002) Leukemia, 16, 902-910.
21. Maurer, B.J., Melton, L., Billups, C., Cabot, M.C., and Reynolds, C.P. (2000) J.Natl. Cancer Inst., 92, 1897-1909.
22. Keshelava, N., Frgala, T., Krejsa, J., Kalous, O., Reynolds, C.P. (2005) Methods in Molecular Medicine Chemosensitivity Vol 1 ed. Blumenthal RD, Totowa: Humana Press pp 139-154.
23. Harrison S (2002) Perspective on the history of tumor models. In BA Teicher (ed.) Tumor Models in Cancer Research. Humana Press, Totwa NJ, pp 3-19.
24. Reynolds, C.P. (2000) Curr. Oncol. Rep., 2, 511-518.
25. Anderson, C. P., Seeger, R. C., Bailey, H. H., and Reynolds, C. P. Proc. Amer. Soc. Clin. Oncol., 21, 298a. 2002.
26. Anderson, C.P. and Reynolds, C.P. (2002) Bone Marrow Transplantation, 30, 135-140.
27. Reynolds, C.P., Wang, Y., Melton, L.J., Einhorn, P.A., Slamon, D.J., and Maurer, B.J. (2000) Med. Pediatr. Oncol., 35, 597-602.
28. Keshelava, N., Tsao-Wei D., and Reynolds, C.P. (2003) Clin. Cancer Res., 9, 3492-3502.
29. Chou, J. and Chou, T.C. (1987) Biosoft, Cambridge, CB2 1LR, pp. 19-29.
30. Ellwart, J.W., Kremer, J.P., and Dormer, P. (1988) Cancer Res., 48, 5722-5725.
31. Weisenthal, L.M., Marsden, J.A., Dill, P.L., and Macaluso, C.K. (1983) Cancer Res., 43, 749-757.
32. Ishiyama, M., Tominaga, H., Shiga, M., Sasamoto, K., Ohkura, Y., and Ueno, K. (1996) Biol. Pharm. Bull., 19, 1518-1520.
33. Sevin, B.U., Peng, Z.L., Perras, J.P., Ganjei, P., Penalver, M., and Averette, H.E. (1988) Gynecol. Oncol., 31, 191-204.
34. Metzger, R., Deglmann, C.J., Hoerrlein, S., Zapf, S., and Hilfrich, J. (2001) Toxicology, 166, 97-108.
35. Bosanquet, A.G. and Bell, P.B. (1996) Leuk. Res., 20, 143-153.
36. Tanigawa, N., Kitaoka, A., Yamakawa, M., Tanisaka, K., and Kobayashi, H. (1996) Anticancer Res., 16, 1925-1930.
37. Csoka, K., Tholander, B., Gerdin, E., de la, T.M., Larsson, R., and Nygren, P. (1997) Int. J. Cancer, 72, 1008-1012.
38. www.tacl.us: TACL T2005-001: ABT-751 with chemotherapy for relapsed childhood ALL.
39. Reynolds, C.P., Maurer, B.J. (2005) Methods in Molecular Medicine Chemosensitivity Vol 1 ed. Blumenthal RD, Totowa: Humana Press pp. 173-184.
40. Grigoryan, R., Keshelava, N., Anderson, C., Reynolds, C.P. (2005) Methods in Molecular Medicine Chemosensitivity Vol 1 ed. Blumenthal RD, Totowa: Humana Press pp. 87-100.
41. Villablanca, J.G., Krailo, M., Ames, M., Reid, J.M., Reaman, G.H., Reynolds, C.P. (2006) J. Clin. Oncol., 24, 3423-3430.
42. Fragala, T., Kalous O., Proffitt R.T., Reynolds, C.P. (2007) Mol. Cancer Ther., 6, 886-897.